Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Steroid Resistant Acute Gut GVHD
NCT04285424Phase 1Unknown
- Sponsor
- Academy of Military Medical Sciences
- Start
- Mar 2020
- Primary completion
- Dec 2021
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fecal microbiome transplant in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Academy of Military Medical Sciences. Primary endpoint: Gut acute Graft-versus-Host Disease (aGvHD) response at 7 days. Status: unknown.
02
Drugs
fecal microbiome transplant
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT04285424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04285424.